603127 Stock Overview
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.76 |
| 52 Week High | CN¥41.07 |
| 52 Week Low | CN¥13.80 |
| Beta | 0.52 |
| 1 Month Change | -14.82% |
| 3 Month Change | -15.31% |
| 1 Year Change | -56.11% |
| 3 Year Change | -68.62% |
| 5 Year Change | n/a |
| Change since IPO | 57.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603127 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -7.5% | -6.5% | -0.2% |
| 1Y | -56.1% | -45.5% | -17.8% |
Return vs Industry: 603127 underperformed the CN Life Sciences industry which returned -48.2% over the past year.
Return vs Market: 603127 underperformed the CN Market which returned -21.1% over the past year.
Price Volatility
| 603127 volatility | |
|---|---|
| 603127 Average Weekly Movement | 8.9% |
| Life Sciences Industry Average Movement | 9.6% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603127's share price has been volatile over the past 3 months.
Volatility Over Time: 603127's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,510 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
| 603127 fundamental statistics | |
|---|---|
| Market cap | CN¥12.21b |
| Earnings (TTM) | CN¥396.99m |
| Revenue (TTM) | CN¥2.38b |
33.4x
P/E Ratio5.6x
P/S RatioIs 603127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603127 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.38b |
| Cost of Revenue | CN¥1.39b |
| Gross Profit | CN¥981.55m |
| Other Expenses | CN¥584.56m |
| Earnings | CN¥396.99m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | 0.53 |
| Gross Margin | 41.30% |
| Net Profit Margin | 16.71% |
| Debt/Equity Ratio | 0% |
How did 603127 perform over the long term?
See historical performance and comparison